Theriva Biologics, Inc. (TOVX)
0.24
0.00 (0.00%)
USD |
NYAM |
Aug 24, 16:00
0.24
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Debt to Equity Ratio : 0.2915 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2915 |
| March 31, 2026 | 0.2398 |
| December 31, 2025 | 0.1709 |
| September 30, 2025 | 0.4099 |
| June 30, 2025 | 0.2721 |
| March 31, 2025 | 0.1842 |
| December 31, 2024 | 0.0821 |
| September 30, 2024 | 0.0706 |
| June 30, 2024 | 0.0662 |
| March 31, 2024 | 0.0591 |
| December 31, 2023 | 0.0543 |
| September 30, 2023 | 0.0506 |
| June 30, 2023 | 0.0493 |
| March 31, 2023 | 0.0487 |
| December 31, 2022 | 0.0308 |
| September 30, 2022 | 0.0285 |
| June 30, 2022 | 0.0275 |
| March 31, 2022 | 0.0261 |
| December 31, 2021 | 0.0233 |
| September 30, 2021 | 0.0215 |
| June 30, 2021 | 0.0212 |
| March 31, 2021 | 0.0051 |
| December 31, 2020 | 0.0589 |
| September 30, 2020 | 0.0807 |
| June 30, 2020 | 0.0692 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0577 |
| December 31, 2019 | 0.0503 |
| September 30, 2019 | 0.0448 |
| June 30, 2019 | 0.0372 |
| March 31, 2019 | 0.0343 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Nkarta, Inc. | 0.2968 |
| Unicycive Therapeutics, Inc. | 0.0139 |
| OnKure Therapeutics, Inc. | 0.0054 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.86M |
| Total Liabilities (Quarterly) | 22.67M |
| Shareholders Equity (Quarterly) | 12.19M |
| Current Ratio | 1.129 |
| Net Debt Paydown Yield | -1.22% |